Molecular Templates MTEM Stock
Molecular Templates Price Chart
Molecular Templates MTEM Financial and Trading Overview
| Molecular Templates stock price | 1.89 USD |
| Previous Close | 0.5 USD |
| Open | 0.5 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 3200 |
| Day's Range | 0.48 - 0.5 USD |
| 52 Week Range | 0.31 - 1.19 USD |
| Volume | 59.96K USD |
| Avg. Volume | 168.94K USD |
| Market Cap | 28.17M USD |
| Beta (5Y Monthly) | 1.388732 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.8 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.5 USD |
MTEM Valuation Measures
| Enterprise Value | 36.83M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.87701756 |
| PEG Ratio (5 yr expected) | -0.21 |
| Price/Sales (ttm) | 0.5881405 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.769 |
| Enterprise Value/EBITDA | -0.753 |
Trading Information
Molecular Templates Stock Price History
| Beta (5Y Monthly) | 1.388732 |
| 52-Week Change | -40.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.19 USD |
| 52 Week Low | 0.31 USD |
| 50-Day Moving Average | 0.45 USD |
| 200-Day Moving Average | 0.52 USD |
MTEM Share Statistics
| Avg. Volume (3 month) | 168.94K USD |
| Avg. Daily Volume (10-Days) | 100.17K USD |
| Shares Outstanding | 56.35M |
| Float | 38.13M |
| Short Ratio | 14.62 |
| % Held by Insiders | 4.88% |
| % Held by Institutions | 69.01% |
| Shares Short | 1.06M |
| Short % of Float | 2.81% |
| Short % of Shares Outstanding | 1.88% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:11 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -125.81% |
| Operating Margin (ttm) | -117.86% |
| Gross Margin | -66.96% |
| EBITDA Margin | -102.096% |
Management Effectiveness
| Return on Assets (ttm) | -29.19% |
| Return on Equity (ttm) | -264.46% |
Income Statement
| Revenue (ttm) | 47.9M USD |
| Revenue Per Share (ttm) | 0.85 USD |
| Quarterly Revenue Growth (yoy) | 331.59% |
| Gross Profit (ttm) | N/A |
| EBITDA | -48901000 USD |
| Net Income Avi to Common (ttm) | -60262000 USD |
| Diluted EPS (ttm) | -1.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.67M USD |
| Total Cash Per Share (mrq) | 0.74 USD |
| Total Debt (mrq) | 50.32M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.727 |
| Book Value Per Share (mrq) | -0.034 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -80689000 USD |
| Levered Free Cash Flow (ttm) | -39226752 USD |
Profile of Molecular Templates
| Country | United States |
| State | TX |
| City | Austin |
| Address | 9301 Amberglen Boulevard |
| ZIP | 78729 |
| Phone | 512 869 1555 |
| Website | https://www.mtem.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 111 |
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company primarily develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Q&A For Molecular Templates Stock
What is a current MTEM stock price?
Molecular Templates MTEM stock price today per share is 1.89 USD.
How to purchase Molecular Templates stock?
You can buy MTEM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Molecular Templates?
The stock symbol or ticker of Molecular Templates is MTEM.
Which industry does the Molecular Templates company belong to?
The Molecular Templates industry is Biotechnology.
How many shares does Molecular Templates have in circulation?
The max supply of Molecular Templates shares is 6.58M.
What is Molecular Templates Price to Earnings Ratio (PE Ratio)?
Molecular Templates PE Ratio is now.
What was Molecular Templates earnings per share over the trailing 12 months (TTM)?
Molecular Templates EPS is -1.8 USD over the trailing 12 months.
Which sector does the Molecular Templates company belong to?
The Molecular Templates sector is Healthcare.
Molecular Templates MTEM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}